Specifically, real-time PCR and IHC data reveal MMP10 overexpression in 58/66 (88%) and 10/13 (77%), and low expression in 8/66 (12%) and 3/13 (23%) of patients with lymph node metastasis, respectively. Here, MMP10 is linked to metastatic malignant neoplasm in the lymph nodes.